Conclusion: Rasagiline is an investigational selective and irreversible inhibitor of MAO-B that has demonstrated efficacy and safety for the treatment of PD. Whether rasagiline is associated with ...

As a reversible inhibitor, harmine temporarily binds to monoamine oxidase A, allowing the enzyme to function again once ...